甲基柏木酮
Search documents
香料“老将”格林生物三闯创业板IPO 核心管理层“扎堆”股东榜引关注
Shang Hai Zheng Quan Bao· 2025-11-23 18:02
香料"老将"格林生物三闯创业板IPO 针对历史问题,格林生物本次募投项目作出针对性安排。格林生物此次IPO拟募集资金6.9亿元,其中 4.2亿元投向"年产6300吨高级香料项目",1.2亿元用于"工厂设施智能化改造",7000万元投入研发升 级,剩余8000万元补充流动资金。据披露,智能化改造项目将重点提升环保治理与安全生产管控能力, 回应此前交易所关注的环保合规问题。 核心管理层"扎堆"股东榜引关注 ◎记者 张雪 近日,深交所IPO"考场"迎来一个熟悉的身影——香料行业知名企业格林生物创业板IPO申请于11月21 日获受理。上海证券报记者梳理发现,这已是格林生物第三次冲刺IPO。 回溯格林生物波折的IPO之路:2020年12月首次申报IPO,格林生物因子公司环保行政处罚未及时披露 以及公司净利润预降等问题撤回;2023年二次申报历经两轮问询后,于2024年9月再度撤回,深交所重 点关注了其环保合规与创业板定位问题。 公司IPO的另一大看点是,管理层"扎堆"股东榜。本次发行前,公司前十名自然人股东均是公司高管、 员工,或离职员工。具体来看,公司副董事长陈东霞持股11.32%,董事陈家德持股9.65%,二人与陆 ...
宝洁香料供应商格林生物三战IPO,数据监测系统供应商英视睿达重启上市辅导
Sou Hu Cai Jing· 2025-07-30 08:24
Group 1: Companies Submitting Listing Counseling Reports - Three companies submitted listing counseling reports for domestic issuance from July 21 to July 27 [2][10] - Beijing Yingshiruida Technology Co., Ltd. focuses on integrating advanced cloud computing and AI technologies for environmental monitoring solutions [3][4] - China Electronics Technology Group Corporation's subsidiary, China Electronics Si Yi Technology Co., Ltd., specializes in electronic measurement instruments [5][6] - Green Biotechnology Co., Ltd. is engaged in the research, production, and sales of synthetic fragrances, with notable clients including international giants [8][9] Group 2: Companies with Terminated Counseling Records - Nine companies had their listing counseling records terminated during the same period [12] - Zhaoqing Chuangfu New Materials Technology Co., Ltd. focuses on aluminum alloy templates and has grown with the promotion of prefabricated construction [14] - Anhui Xici Technology Co., Ltd. specializes in magnetic sensors and provides solutions for various industries [15] - Shenzhen Jinxun Technology Co., Ltd. offers smart lighting and wireless audio solutions [16] - Shanghai Keliang Information Technology Co., Ltd. provides simulation testing products for multiple industries [17] - Bojing Ecological Environment Co., Ltd. operates in integrated environmental management services [18] - Shenzhen Zhenghao Innovation Technology Co., Ltd. is a leader in mobile energy storage and clean energy technology [19] - Guangzhou Hanxin Communication Technology Co., Ltd. provides mobile communication network optimization solutions [20] - Anhui Fengyang Glass Co., Ltd. produces high-quality float glass and processed products [21] - Shanghai Zhengshi Technology Co., Ltd. is a multinational high-tech enterprise in the diamond manufacturing sector [22]
最大,知名原料商三战IPO
3 6 Ke· 2025-07-29 02:29
Core Viewpoint - Green Biological Technology Co., Ltd. (hereinafter referred to as Green Biological) is making another attempt to go public (IPO) after two previous unsuccessful attempts, amidst a renewed wave of IPOs in the cosmetics raw material sector [1][2][5]. Company Overview - Green Biological was established in December 1999, focusing on the research, production, and sales of bio-based and fully synthetic fragrances. Its product lines include turpentine, cedarwood oil, and various synthetic fragrances [2][5]. - The company is one of the largest suppliers of methyl cedryl ketone in China, with significant usage in household and high-end perfume products [2][5]. - The founder, Lu Wencong, holds 27.11% of the company's shares, and his daughter holds an additional 9%, making them the actual controllers of the company [6][7]. IPO Attempts - Green Biological's first IPO attempt began in 2018, but it was halted in early 2021 due to issues related to information disclosure and a significant expected drop in net profit [5][9]. - The second attempt in June 2023 also ended in withdrawal due to similar concerns raised by the Shenzhen Stock Exchange regarding environmental issues and innovation capabilities [5][9]. Financial Performance - The company has shown strong revenue growth, with revenues of 594 million, 631 million, and 735 million yuan from 2021 to 2023, representing growth rates of 6.23%, 16.48%, and a compound annual growth rate of 10.92% [9][10]. - Net profits for the same period were 201.7 million yuan, with growth rates of 65.85% and 32.35% in 2022 and 2023, respectively, leading to a compound growth rate of 48.43% [9][10]. - As of the end of 2023, total assets reached 1.433 billion yuan, with a net profit of 92.92 million yuan and a return on equity of 20.65% [10][11]. Market Context - The cosmetics raw material market in China is projected to grow from 1147.80 billion yuan in 2019 to 1603.90 billion yuan by 2024, with a compound annual growth rate of 6.9% [14]. - The recent surge in IPOs among raw material suppliers is attributed to the booming cosmetics industry and favorable regulatory changes, including the establishment of the Beijing Stock Exchange and reforms in the Sci-Tech Innovation Board [15][16][17]. - Green Biological's export revenue has been significant, accounting for over 84% of its main business from 2021 to 2023, with major clients including Procter & Gamble and other international raw material suppliers [11][12].